HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey Weitz Selected Research

Jeffrey Weitz Research Topics

Disease

5Hemorrhage
02/2022 - 07/2002
3Stroke (Strokes)
06/2018 - 09/2002
2Embolic Stroke
06/2018 - 09/2016
2Embolism (Embolus)
06/2018 - 09/2016
2Thrombosis (Thrombus)
05/2003 - 07/2002
1Chronic Kidney Failure (Chronic Renal Failure)
02/2022
1Venous Thromboembolism
11/2019
1Neoplasms (Cancer)
11/2019
1Arthritis (Polyarthritis)
01/2017
1Brain Infarction
09/2016
1Glioma (Gliomas)
04/2010
1Heart Diseases (Heart Disease)
04/2007

Drug/Important Bio-Agent (IBA)

4AnticoagulantsIBA
11/2019 - 07/2002
2RivaroxabanIBA
06/2018 - 09/2016
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2018 - 09/2016
2Factor Xa (Coagulation Factor Xa)IBA
06/2018 - 09/2016
1Factor XI (Plasma Thromboplastin Antecedent)IBA
02/2022
1edoxabanIBA
11/2019
1Dalteparin (Dalteparin Sodium)FDA Link
11/2019
1Naproxen (Naprosyn)FDA LinkGeneric
01/2017
1Celecoxib (Celebrex)FDA Link
01/2017
1Biomarkers (Surrogate Marker)IBA
09/2016
1Factor Xa InhibitorsIBA
09/2016
1ErbB Receptors (EGF Receptor)IBA
04/2010
1Factor VII (Proconvertin)IBA
04/2010
1LigandsIBA
04/2010
1Proteinase-Activated ReceptorsIBA
04/2010
1epidermal growth factor receptor VIIIIBA
04/2010
1Warfarin (Coumadin)FDA LinkGeneric
09/2002
1ThrombinFDA Link
07/2002
1Heparinoids (Heparinoid)IBA
07/2002
1AntithrombinsIBA
07/2002
1Heparin Cofactor IIIBA
07/2002
1Heparin (Liquaemin)FDA LinkGeneric
07/2002

Therapy/Procedure

1Renal Dialysis (Hemodialysis)
02/2022
1Therapeutics
11/2019
1Secondary Prevention
09/2016
1Stroke Rehabilitation
09/2002